ArticleFrontiers in oncology2023

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.

Cheng Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.